Approximately half of patients in group A (26/50 patients, 52%) and about two-thirds of patients in group B (69/100, 69%) had biopsy-proven PCA at the time of the scan, whereas PCA was suspected in the remaining cases due to elevated PSA. This evidence concerns the gene KLK3 and posterior cortical atrophy.